ATM and ATR mutant cells are hypersensitive to TMZ, and pharmacological inhibition of ATM or ATR after TMZ treatment of glioblastoma cells resulted in an increase in the rate of apoptosis [43], which led to an indication that repair proteins (including BRCA2) are activated via the damage response triggered by TMZ. The gene discussed is ATM; the disease is glioblastoma.